Previous close | 10.40 |
Open | 10.40 |
Bid | 8.60 |
Ask | 13.50 |
Strike | 35.00 |
Expiry date | 2026-01-16 |
Day's range | 10.40 - 10.40 |
Contract range | N/A |
Volume | |
Open interest | 290 |
Q4 2024 Roivant Sciences Ltd Earnings Call
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.